TORONTO and DUREN, Germany, June 5, 2023
/CNW/ - GBLT Corp. (TSXV: GBLT) ("GBLT" or the
"Company") is pleased to announce that the Company has
completed the necessary testing requirements and successfully
established legal assurances to be able to fully distribute CBD
products to the German market.
"We are proud to announce this pinnacle milestone in our
Company's history as we enter the CBD market with our high quality,
lab-tested line of Dr. Senst CBD products," said Dr. Thilo Senst, CEO of GBLT. "We look forward to
being a trailblazer in the early-stage market here in Germany as we plan to leverage the brand
recognition power of our Dr. Senst brand. We are also fortunate to
have such a robust distribution network with major retailers and
distributors at our disposal, established due to the years of
providing quality battery and portable energy products, as they
have proved historically to be an easy initial gateway to expand
our product offerings."
Dr. Senst Continued, "With the successful legal assurances we
have received, we can now confidently focus on fully scaling and
expanding the CBD business into our large distribution networks and
establish significant market share in the German market while it is
still in its formative stage. Due to our aggressive plans to expand
and diversify our revenue streams, the high quality Dr. Senst CBD
products will be one of the first to be available in large physical
retail locations in Germany as
well as a source for sticky long-term revenue with high margins for
the Company."
About GBLT:
GBLT Corp., through its operating company, GBT GmbH, designs,
manufactures and supplies mobile storage, and battery solutions.
GBLT is also a leading provider of renewable energy solutions via
its solar division, participating in the rapidly growing solar
energy market. In addition, the Company offers consumer healthcare
and wellness products to some of the largest retail chains across
the globe. GBT is also an official licensee for AGFAPHOTO mobile
energy products. The Company's branded healthcare and wellbeing
products are primarily sold throughout Europe under Dr. Senst brand.
For more information, please visit www.gbt-international.com and
www.gbltcorp.com.
Forward-Looking
Information
Certain statements in this news release, which are not
historical in nature, constitute "forward looking statements"
within the meaning of that phrase under applicable Canadian
securities law. These statements include, but are not limited to,
statements or information concerning the Company's proposed
activities under the Agreement, the Company's ability to achieve
sales, commercial or otherwise, from its products, and the
expectations of the Company regarding funding payments due pursuant
to the Agreement. These statements reflect management's current
assumptions and expectations and by their nature are subject to
certain underlying assumptions, known and unknown risks and
uncertainties and other factors which may cause actual results,
performance or events to be materially different from those
expressed or implied by such forward looking statements. Except as
required pursuant to applicable securities laws, the Company will
not update these forward-looking statements to reflect events or
circumstances after the date hereof. More detailed information
about potential factors that could affect financial results is
included in the documents filed from time to time with the Canadian
securities regulatory authorities by the Company. Readers are
cautioned not to place undue reliance on forward looking
statements.
Neither the TSX Venture Exchange nor its
Regulation Services Provider
(as that term is defined in the policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
SOURCE GBLT Corp.
